CAIRO: The Ministry of Health has launched a website for hepatitis C patients to register to receive Solvadi, a new imported American treatment, said Health Minister Adel el-Adawy in a Saturday conference, Youm7 reported.
Scheduled to be activated Sep. 18, the website is meant to ease patient registration procedures and avoid long queues at hospitals and treatment centers, Adawy added.
Patients between 18- to 70-years-old will have to enter their national ID number online, and within 24 hours they will get an appointment at one of the medical centers across the country according to their location.
Already 60,000 patients are scheduled to be treated with the new treatment, Youm7 reported.
The National Committee to Combat Hepatitis Viruses (NCCHV) announced during the conference that more than 700 doctors and administrative members of treatment units at the committee were trained to administer the new medicine.
Egypt was one of the countries that received the new treatment from American medical firm Gilead at a decreased price, as Adawy previously stated in July that “Egypt bought the treatment for 1 percent of its original international price.”
The price of one Sovaldi pack (28 pills) in the United States is $28,000, according to NCCHV chief Waheed Dous in comments to Veto Gate on Aug. 18.
It was declared that the first shipment for Egypt will include 225,000 packs of Sovaldi for 450 million EGP ($63 million), and the price of one pack of Sovaldi in Egypt will be 2,200 EGP ($307).
Egypt has the highest Hepatitis C prevalence in the world, according to the United Nations Population Fund website. Of the total population, 14.7 percent of people between ages 15-49 have tested positive for the virus.
Additional Reporting by Dana el-Hadidi and Randa el-Banna